4.8 Article

Discovery of Ubiquitin Deamidases in the Pathogenic Arsenal of Legionella pneumophila

Journal

CELL REPORTS
Volume 23, Issue 2, Pages 568-583

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2018.03.060

Keywords

-

Categories

Funding

  1. Princess Margaret Cancer Centre of the University Health Network
  2. NIH (through the Midwest Center for Structural Genomics) [GM074942, GM094585]
  3. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]
  4. CIHR [MOP-133406]
  5. University of Toronto Department of Biochemistry
  6. Canada Foundation for Innovation [30364]
  7. Ontario Research Fund

Ask authors/readers for more resources

Legionella pneumophila translocates the largest known arsenal of over 330 pathogenic factors, called effectors,'' into host cells during infection, enabling L. pneumophila to establish a replicative niche inside diverse amebas and human macrophages. Here, we reveal that the L. pneumophila effectors MavC (Lpg2147) and MvcA (Lpg2148) are structural homo-logs of cycle inhibiting factor (Cif) effectors and that the adjacent gene, lpg2149, produces a protein that directly inhibits their activity. In contrast to canonical Cifs, both MavC and MvcA contain an insertion domain and deamidate the residue Gln40 of ubiquitin but not Gln40 of NEDD8. MavC and MvcA are functionally diverse, with only MavC interacting with the human E2-conjugating enzyme UBE2N (Ubc13). MavC deamidates the UBE2N similar to Ub conjugate, disrupting Lys63 ubiquitination and dampening NF-kappa B signaling. Combined, our data reveal a molecular mechanism of host manipulation by pathogenic bacteria and highlight the complex regulatory mechanisms integral to L. pneumophila's pathogenic strategy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available